Log in

The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

A Correction to this article was published on 07 December 2020

This article has been updated

Abstract

The current pharmacotherapy of neuropathic pain is inadequate as neuropathic pain involves varied clinical manifestations with multifactorial etiology, modulated by a cascade of physical and molecular events leading to different clinical presentations of pain. There is an accumulating evidence of the involvement of oxidative stress in neuropathy, and antioxidants have shown promise in mitigating neuropathic pain syndromes. To explore the evidence supporting this beneficial proclivity of antioxidants, this study investigated the antinociceptive effectiveness of N-(2-mercaptopropionyl)glycine or tiopronin, a well-recognized aminothiol antioxidant, in a refined chronic constriction injury (CCI) rat model of neuropathic pain. Tiopronin (10, 30, and 90 mg/kg, i.p.) and pregabalin (30 mg/kg, i.p.) were administered daily after CCI surgery. The neuropathic paradigms of mechanical/cold allodynia and mechanical/heat hyperalgesia were assessed on days 3, 7, 14, and 21 post-nerve ligation. At the end of study, malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH) levels were estimated in the sciatic nerve, dorsal root ganglion, and spinal cord for assessing the extent of oxidative stress. The expression of neuropathic nociception was attenuated by tiopronin which was observed as a significant attenuation of CCI-induced allodynia and hyperalgesia. Tiopronin reversed the neuronal oxidative stress by significantly reducing MDA, and increasing SOD, CAT, and GSH levels. Pregabalin also showed similar beneficial propensity on CCI-induced neuropathic aberrations. These findings suggest prospective neuropathic pain attenuating efficacy of tiopronin and further corroborated the notion that antioxidants are effective in mitigating the development and expression of neuropathic pain and underlying neuronal oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

The authors declare that the data supporting the findings of this study are available within the article (and its supplementary information file).

Change history

References

Download references

Acknowledgments

We are thankful to Wilshire Laboratories (Pvt.) Ltd., Lahore, Pakistan, for the supply of pregabalin active material.

Code availability

Tiopronin (PubChem CID: 5483), Pregabalin (PubChem CID: 5486971).

Author information

Authors and Affiliations

Authors

Contributions

FS as research supervisor guided the research group in planning and conducting experiments throughout the study duration. MS, NA, and UF performed the experiments, interpreted the data, and carried out necessary statistical analysis. SAb, SAk, IU, NR, and ZUD provided inputs on the research work at different stages. MS prepared the initial draft of the manuscript. NUI critically revised the manuscript for important intellectual content. All authors read and approved the manuscript and all data were generated in-house and that no paper mill was used.

Corresponding authors

Correspondence to Muhammad Shahid or Fazal Subhan.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethics approval

The experimental procedures on animals were performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and were approved by the Ethical Committee of the Department of Pharmacy, University of Peshawar (Reference No. 13/EC-15/Pharm). Moreover, these experimental protocols also conformed to the guidelines of Animal Research: Reporting In Vivo experiments (ARRIVE) and International Association for the Study of Pain (IASP).

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 29.2 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahid, M., Subhan, F., Islam, N.U. et al. The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia. Naunyn-Schmiedeberg's Arch Pharmacol 394, 603–617 (2021). https://doi.org/10.1007/s00210-020-01995-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-020-01995-y

Keywords

Navigation